This article provides a detailed and up-to-date analysis of CAR-NK (Chimeric Antigen Receptor-Natural Killer) cell therapy, a rapidly evolving frontier in immuno-oncology and drug development.
This article provides a comprehensive review of the validation and application of the CAR-HEMATOTOX (HT) score, a predictive model for prolonged cytopenias and infectious complications following CD19-directed CAR T-cell therapy.
This article provides a comprehensive overview of bulk RNA-seq deconvolution for estimating immune cell infiltration, a critical technique in immunology and immuno-oncology research.
Immune checkpoint inhibitors (ICIs) have transformed oncology, but not all patients respond, highlighting a critical need for predictive biomarkers.
This article provides a comprehensive roadmap for researchers and drug development professionals navigating the complex landscape of biomarker validation for immunotherapy.
This comprehensive review synthesizes current research on biomarkers for predicting response to immunotherapy.
This comprehensive guide provides researchers, scientists, and drug development professionals with a practical framework for successful cancer biomarker development.
This article provides a comprehensive guide to Bayesian adaptive methods within master protocol trials for drug development professionals.
This article provides a comprehensive examination of the core principles of cancer immunoediting and immune surveillance, tailored for researchers and drug development professionals.
This article provides a comprehensive overview of BMI-1 (B-cell-specific Moloney murine leukemia virus integration site 1) as a master regulator of cancer stem cell (CSC) stemness and a promising therapeutic...